ISDA: 4J53

Deposition Date 2013-02-07

Release Date 2013-05-29

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4J53

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Crystal structure of PLK1 in complex with TAK-960

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.50 Å

R-Value Free:

0.24

R-Value Work:

0.17

R-Value Observed:

0.18

Space Group:

P 32 2 1

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Serine/threonine-protein kinase PLK1
Gene (Uniprot):PLK1
Mutagens:T210V
Chain IDs:A
Chain Length:293
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P53350 Pfam ID:PF00069 EC:2.7.11.21

Ligand Molecules

1J4

ACT

Primary Citation

Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1).

Nie, Z, Feher, V, Natala, S, McBride, C, Kiryanov, A, Jones, B, Lam, B, Liu, Y, Kaldor, S, Stafford, J, Hikami, K, Uchiyama, N, Kawamoto, T, Hikichi, Y, Matsumoto, S, Amano, N, Zhang, L, Hosfield, D, Skene, R, Zou, H, Cao, X, Ichikawa, T.Show

Bioorg.Med.Chem.Lett. 23 3662 3666 (2013)

PMID: 23664874 DOI: 10.1016/j.bmcl.2013.02.083

Abstact

Using structure-based drug design, we identified and optimized a novel series of pyrimidodiazepinone PLK1 inhibitors resulting in the selection of the development candidate TAK-960. TAK-960 is currently undergoing Phase I evaluation in adult patients with advanced solid malignancies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form